Francisella novicida and F. philomiragia biofilm features conditionning fitness in spring water and in presence of antibiotics

PLoS One. 2020 Feb 5;15(2):e0228591. doi: 10.1371/journal.pone.0228591. eCollection 2020.

Abstract

Biofilms are currently considered as a predominant lifestyle of many bacteria in nature. While they promote survival of microbes, biofilms also potentially increase the threats to animal and public health in case of pathogenic species. They not only facilitate bacteria transmission and persistence, but also promote spreading of antibiotic resistance leading to chronic infections. In the case of Francisella tularensis, the causative agent of tularemia, biofilms have remained largely enigmatic. Here, applying live and static confocal microscopy, we report growth and ultrastructural organization of the biofilms formed in vitro by these microorganisms over the early transition from coccobacillary into coccoid shape during biofilm assembly. Using selective dispersing agents, we provided evidence for extracellular DNA (eDNA) being a major and conserved structural component of mature biofilms formed by both F. subsp. novicida and a human clinical isolate of F. philomiragia. We also observed a higher physical robustness of F. novicida biofilm as compared to F. philomiragia one, a feature likely promoted by specific polysaccharides. Further, F. novicida biofilms resisted significantly better to ciprofloxacin than their planktonic counterparts. Importantly, when grown in biofilms, both Francisella species survived longer in cold water as compared to free-living bacteria, a trait possibly associated with a gain in fitness in the natural aquatic environment. Overall, this study provides information on survival of Francisella when embedded with biofilms that should improve both the future management of biofilm-related infections and the design of effective strategies to tackle down the problematic issue of bacteria persistence in aquatic ecosystems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Physiological
  • Anti-Bacterial Agents / pharmacology
  • Biofilms*
  • Ciprofloxacin / pharmacology
  • Conserved Sequence
  • DNA, Bacterial / chemistry
  • Drug Resistance, Bacterial*
  • Francisella / drug effects
  • Francisella / genetics
  • Francisella / pathogenicity
  • Francisella / physiology*
  • Fresh Water / microbiology*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Ciprofloxacin

Supplementary concepts

  • Francisella philomiragia
  • Francisella tularensis subsp. novicida

Grants and funding

This work was supported by the FINOVI Foundation (Grant AO12-02) and by the ANR ASTRID (grant ANR-17-ASTR-0024). NY Yakandawala was employed by the company Kane Biotech, Inc. (Winnipeg, Canada). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.